BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15064863)

  • 1. Deletion (11)(q13) as the sole anomaly in myeloid malignancies: four new cases and a short review.
    Panani AD; Pappa V; Papageorgiou S; Stamatelli F; Raptis SA
    Ann Hematol; 2004 Mar; 83(3):153-5. PubMed ID: 15064863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.
    Douet-Guilbert N; Basinko A; Morel F; Le Bris MJ; Ugo V; Morice P; Berthou C; De Braekeleer M
    Ann Hematol; 2008 Jul; 87(7):537-44. PubMed ID: 18350294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 5q deletion: specific diagnoses and cytogenetic details among 358 consecutive cases from a single institution.
    Santana-Davila R; Holtan SG; Dewald GW; Ketterling RP; Knudson RA; Hanson CA; Steensma DP; Tefferi A
    Leuk Res; 2008 Mar; 32(3):407-11. PubMed ID: 17707907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
    Swolin B; Rödjer S; Westin J
    Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverted duplication dup(1)(q32q21) as sole aberration in lymphoid and myeloid malignancies.
    Bacher U; Schnittger S; Grüneisen A; Haferlach T; Kern W; Haferlach C
    Cancer Genet Cytogenet; 2009 Jan; 188(2):108-11. PubMed ID: 19100515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies.
    Giagounidis AA; Germing U; Aul C
    Clin Cancer Res; 2006 Jan; 12(1):5-10. PubMed ID: 16397017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome 1 abnormalities in myeloid malignancies: a literature survey and karyotype-phenotype associations.
    Caramazza D; Hussein K; Siragusa S; Pardanani A; Knudson RA; Ketterling RP; Tefferi A
    Eur J Haematol; 2010 Mar; 84(3):191-200. PubMed ID: 20002154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isochromosome of a deleted 20q: a rare but recurrent chromosome abnormality in myelodysplastic syndromes.
    Saunders K; Czepulkowski B; Sivalingam R; Hayes JP; Aldouri M; Sekhar M; Cummins M; Ho A; Mufti GJ
    Cancer Genet Cytogenet; 2005 Jan; 156(2):154-7. PubMed ID: 15642396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion (20q) as the sole abnormality in Waldenström macroglobulinemia suggests distinct pathogenesis of 20q11 anomaly.
    Liu YC; Miyazawa K; Sashida G; Kodama A; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Aug; 169(1):69-72. PubMed ID: 16875940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic syndromes with isolated deletion of the long arm of the chromosome X as a sole cytogenetic change.
    Olshanskaya YV; Udovichenko AI; Vodinskaya LA; Glasko EN; Parovitchnikova EN; Lorie YY; Dvirnik VN; Savchenko VG; Domracheva EV
    Cancer Genet Cytogenet; 2006 May; 167(1):47-50. PubMed ID: 16682286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic survey of sixty-one patients with preleukemic syndrome including myeloproliferative and myelodysplastic diseases.
    Palka G; Spadano A; Calabrese G; Parruti G; Guanciali Franchi P; Di Sante O; Recchia A; Di Lorenzo R; Torlontano G
    Ann Genet; 1990; 33(4):214-8. PubMed ID: 2095702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.
    Beyer V; Mühlematter D; Parlier V; Cabrol C; Bougeon-Mamin S; Solenthaler M; Tobler A; Pugin P; Gregor M; Hitz F; Hess U; Chapuis B; Laurencet F; Schanz U; Schmidt PM; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2005 Jul; 160(2):97-119. PubMed ID: 15993266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbalanced translocation der(11)t(11;12)(q23;q13): a new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype.
    Yamamoto K; Hato A; Minagawa K; Yakushijin K; Urahama N; Gomyo H; Sada A; Okamura A; Ito M; Matsui T
    Cancer Genet Cytogenet; 2004 Nov; 155(1):67-73. PubMed ID: 15527905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelodysplastic syndromes associated with interstitial deletion of chromosome 5q: clinicopathologic correlations and new insights from the pre-lenalidomide era.
    Holtan SG; Santana-Davila R; Dewald GW; Khetterling RP; Knudson RA; Hoyer JD; Chen D; Hanson CA; Porrata L; Tefferi A; Steensma DP
    Am J Hematol; 2008 Sep; 83(9):708-13. PubMed ID: 18634051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders.
    Campbell LJ; Garson OM
    Leukemia; 1994 Jan; 8(1):67-71. PubMed ID: 8289501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion 15q as the sole abnormality in acute myeloid leukemia: report of three cases and review of the literature.
    Lu G; Yin CC; Medeiros LJ; Abruzzo LV
    Cancer Genet Cytogenet; 2009 Jan; 188(2):118-23. PubMed ID: 19100517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlapping deletion regions at 11q23 in myelodysplastic syndrome and chronic lymphocytic leukemia, characterized by a novel BAC probe set.
    Siew-Gek Lee A; Rudduck-Sivaswaren C; Khun-Hong Lie D; Li-Ming Chua C; Tien SL; Morsberger L; Griffin CA
    Cancer Genet Cytogenet; 2004 Sep; 153(2):151-7. PubMed ID: 15350305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG).
    Bench AJ; Nacheva EP; Hood TL; Holden JL; French L; Swanton S; Champion KM; Li J; Whittaker P; Stavrides G; Hunt AR; Huntly BJ; Campbell LJ; Bentley DR; Deloukas P; Green AR
    Oncogene; 2000 Aug; 19(34):3902-13. PubMed ID: 10952764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryptic translocations involving chromosome 20 in polycythemia vera.
    Busson M; Romana S; Nguyen Khac F; Bernard O; Berger R
    Ann Genet; 2004; 47(4):365-71. PubMed ID: 15581834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.